ClinicalTrials.gov record

Completed No phase listed Interventional Accepts healthy volunteers Results available

Oxygen Reserve Index Validation for RD Lite Sensors

ClinicalTrials.gov ID: NCT03128892

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03128892. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Oxygen Reserve Index (ORI) is a parameter that provides information on arterial partial pressure of oxygen (PaO2). In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. The ORI device measurement is analyzed by comparing it to the PaO2 measurements from a laboratory analyzer.

Study identification

NCT ID: NCT03128892
Recruitment status: Completed
Study type: Interventional
Phase: Not listed
Lead sponsor: Masimo Corporation; Industry
Enrollment: 34 participants

Conditions and interventions

Conditions

Healthy

Interventions

Oxygen Reserve Index - RD Lite Sensors Device

Device

Eligibility (public fields only)

Age range: 18 Years to 50 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 10, 2016 (Actual)
Primary completion: Mar 29, 2017 (Actual)
Completion: Mar 29, 2017 (Actual)
Last update posted: Mar 1, 2021

2016 – 2017

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Masimo Corporation	Irvine	California	92618	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03128892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 1, 2021 · Synced Nov 15, 2026